AlphaMark Advisors’s Celgene Corp CELG Stock Holding History

AlphaMark Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-44,296	Closed	-$4.4M	–	537
2019 Q3	$4.4M	Sell	44,296 -741	-2%	-$70.4K	1.91%	13
2019 Q2	$4.16M	Sell	45,037 -1,777	-4%	-$169K	1.82%	14
2019 Q1	$4.42M	Buy	+46,814	New	+$4.09M	1.87%	12
2018 Q1	–	Sell	-7	Closed	-$1K	–	548
2017 Q4	$1K	Sell	7 -65	-90%	-$7.33K	﹤0.01%	498
2017 Q3	$10K	Hold	72	–	–	﹤0.01%	342
2017 Q2	$9K	Hold	72	–	–	﹤0.01%	363
2017 Q1	$9K	Buy	72 +46	+177%	+$5.5K	﹤0.01%	350
2016 Q4	$3K	Buy	26 +1	+4%	+$111	﹤0.01%	427
2016 Q3	$3K	Hold	25	–	–	﹤0.01%	324
2016 Q2	$2K	Hold	25	–	–	﹤0.01%	319
2016 Q1	$3K	Hold	25	–	–	﹤0.01%	293
2015 Q4	$3K	Hold	25	–	–	﹤0.01%	281
2015 Q3	$3K	Hold	25	–	–	﹤0.01%	269
2015 Q2	$3K	Hold	25	–	–	﹤0.01%	277
2015 Q1	$3K	Hold	25	–	–	﹤0.01%	280
2014 Q4	$3K	Hold	25	–	–	﹤0.01%	279
2014 Q3	$2K	Buy	+25	New	+$2.26K	﹤0.01%	304

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

AlphaMark Advisors's CELG Position: Q4 2019 in Review

AlphaMark Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 44,296 shares — an estimated $4.4M sold.

AlphaMark Advisors first reported a position in CELG in Q3 2014 and held it in 17 quarters. The position peaked at $4.42M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

AlphaMark Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
AlphaMark Advisors sold 44,296 Celgene Corp shares in Q4 2019, an estimated $4.4M.
AlphaMark Advisors first reported a position in Celgene Corp in Q3 2014 and held it in 17 quarters.
AlphaMark Advisors's Celgene Corp position peaked at $4.42M in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on AlphaMark Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.